Recall: D-0012-2025

Class I - Dangerous

Class IClassification

2024-09-17Initiated

TerminatedStatus

Bionpharma Inc.Firm

Product

Atovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, NDC # 69452-252-87.

Reason

Microbial Contamination of a Non-sterile Product: The product was found to be contaminated with Cohnella bacteria.

Distribution

Nationwide in the U.S.A.

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.